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Abstract
Mammalian MANF and CDNF proteins are evolutionarily conserved neurotrophic factors that can protect and repair
mammalian dopaminergic neurons in vivo. In Drosophila, the sole MANF protein (DmManf) is needed for the maintenance
of dopaminergic neurites and dopamine levels. Although both secreted and intracellular roles for MANF and CDNF have
been demonstrated, very little is known about the molecular mechanism of their action. Here, by using a transgenic rescue
approach in the DmManf mutant background we show that only full-length MANF containing both the amino-terminal
saposin-like and carboxy-terminal SAP-domains can rescue the larval lethality of the DmManf mutant. Independent N- or C-
terminal domains of MANF, even when co-expressed together, fail to rescue. Deleting the signal peptide or mutating the
CXXC motif in the C-terminal domain destroys the activity of full-length DmManf. Positively charged surface amino acids
and the C-terminal endoplasmic reticulum retention signal are necessary for rescue of DmManf mutant lethality when
DmManf is expressed in a restricted pattern. Furthermore, rescue experiments with non-ubiquitous expression reveals
functional differences between the C-terminal domain of human MANF and CDNF. Finally, DmManf and its C-terminal
domain rescue mammalian sympathetic neurons from toxin-induced apoptosis in vitro demonstrating functional similarity
of the mammalian and fly proteins. Our study offers further insights into the functional conservation between invertebrate
and mammalian MANF/CDNF proteins and reveals the importance of the C-terminal domain for MANF activity in vivo.
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Introduction
Neurotrophic factors (NTFs) protect neurons from apoptotic
death and promote their regeneration. During development,
NTFs regulate neuronal migration, differentiation, maturation,
and survival, but also have roles in non-neuronal tissues (reviewed
in [1]). The recently discovered MANF/CDNF family of NTFs
consists of two paralogues in mammals, MANF (Mesencephalic
Astrocyte-derived Neurotrophic Factor; ARMET) [2] and CDNF
(Cerebral Dopamine Neurotrophic Factor) [3]. The sole homo-
logue found in invertebrates is more closely related to mammalian
MANF than CDNF [4]. Recombinant human MANF (HsMANF)
and CDNF (HsCDNF) protect and repair midbrain dopaminergic
(DA) neurons in rodent models of Parkinson’s disease in vivo
[3,5,6]. Mammalian MANF can also rescue cortical neurons and
cardiomyocytes from ischemia in vivo [7,8]. Importantly, the fly
homologue (DmManf) protects DA neurites and maintains DA
levels during Drosophila development in vivo [4]. Based on their DA
neuron survival-promoting and neuro-restorative effects, the
MANF/CDNF family of proteins has therapeutic potential for
treatment of Parkinson’s disease.
The molecular mechanisms behind the protective properties of
MANF/CDNF proteins are still unknown. In addition to the role
as a secreted extracellular trophic factor, MANF localizes to the
endoplasmic reticulum (ER) and provides a protective function
against ER stress in vitro [9–12]. Consistent with the ER function,
both HsMANF and DmManf contain putative ER retention signal
sequences (RTDL and RSEL, respectively; Figure 1A–B) in the C-
terminal end which resemble the canonical KDEL ER retention
signal. The expression of mammalian MANF is up-regulated by
chemically induced ER stress in vitro [9,10]. During ER stress, the
ER homeostasis is disturbed by accumulation of unfolded proteins
leading to activation of the unfolded protein response (UPR;
reviewed in [13,14]). MANF is also shown to bind to a UPR-
related ER-resident protein, Glucose-regulated protein 78
(GRP78) in a Ca2+-dependent manner in vitro [8].
Structurally MANF and CDNF proteins show no amino acid
sequence homology to other known families of NTFs, e.g.
neurotrophins and glial-cell-line-derived neurotrophic factor
(GDNF) family ligands. Human MANF and CDNF consist of
two a-helical domains connected by a short flexible linker region
(Figure 1A) [15–17]. DmManf is expected to adopt a very similar
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structure because of the high similarity of amino acid sequence
and the strict conservation of the spacing between the eight
cysteine residues (Figure 1B). The amino (N) -terminal domain (N-
MANF and N-CDNF) is structurally homologous to saposin-like
proteins (SAPLIPs), a family of lipid-interacting molecules [15–
19]. The C-terminal domain (C-MANF and C-CDNF) shares the
highest structural homology with the SAF-A/B, Acinus and PIAS
(SAP) domain of Ku70 protein [17]. Ku70, via the SAP-domain,
interacts with a pro-apoptotic protein BCL-2 associated X (Bax) in
the cytoplasm and inhibits Bax-mediated apoptotic death of
mammalian cells in vitro [19]. Similar to Ku70, MANF and
cytoplasmic C-MANF protect superior cervical ganglion (SCG)
neurons from apoptosis in vitro [17]. The C-terminal domain also
contains a CXXC motif (127CKGC130 and 126CDGC129 in
HsMANF and DmManf, respectively, Figure 1A–B) which forms a
disulphide bridge [15,17] and may participate in oxidation/
reduction reactions as a similar CXXC sequence is found in thiol/
disulphide oxidoreductases [20].
We have shown in a previous study that zygotic DmManf mutant
flies die as late first instar larvae and are rescued by ubiquitous
expression of transgenic Drosophila and human MANF [4]. Here,
we used a transgenic approach in the homozygous DmManf-
deficient mutant fly background to characterize the structural
features essential for in vivo functioning of the DmManf, HsMANF
and HsCDNF proteins. Mutations in Drosophila and human
MANF and CDNF (Figure 1C–D) were designed based on their
known three-dimensional structures [15,17] and amino acid
sequence predictions (Figure 1A–B). Mutations were introduced
to Drosophila as UAS (upstream activation sequence) -transgenes
and expressed ubiquitously by the da-GAL4 driver in the
homozygous DmManf mutant background (Figure 1E). We also
studied the conserved role of DmManf in protection of mamma-
lian sympathetic neurons from apoptotic death in vitro.
Results
Separate N- and C-terminal Domains Fail to Rescue
DmManf Mutant Lethality
To explore the function of the two domains of MANF
(Figure 1A) we asked whether either of the domains, as an
independent unit, could rescue DmManf mutant lethality in vivo.
First, the N-terminal (residues 1–94) or C-terminal domain
(residues 95–151) of mature DmManf was expressed ubiquitously
by da-GAL4 either with (N-DmManf, C-DmManf) or without a
signal peptide (residues ss2–ss22; N-DmManf-Dss, C-DmManf-
Dss; Figure 1B–C) in the DmManf mutant background. In contrast
to full-length DmManf, none of these constructs could rescue the
early larval lethality (Table 1). The expression of N- and C-
terminal UAS-transgenes was verified by overexpressing the
constructs by ubiquitous da-GAL4 in wild type background.
Expression of N-DmManf and C-DmManf with a signal peptide
was detected from larval lysates by Western blotting (Figure 2A).
Unfortunately, the protein expression level of N-DmManf-Dss and
C-DmManf-Dss constructs which lack the signal peptide was
below the detection limit. Reverse transcription polymerase chain
reaction (RT-PCR) from 1st instar larvae indicated that the
mRNAs were expressed in vivo (Figure 2B) suggesting that either
the translation or the stability of N-DmManf-Dss and C-DmManf-
Dss proteins were compromised.
Next we studied whether the DmManf mutant lethality can be
rescued by the N- and C-terminal domains of DmManf expressed
together as two separate transgenes by ubiquitous da-GAL4 driver
(Figure S1A). Interestingly, the two co-expressed independent
domains also failed to complement the loss of endogenous
DmManf (Table 1) suggesting that intact DmManf protein
containing both domains is needed for in vivo activity.
Interestingly, when wild type DmManf was overexpressed, a
second very faint band corresponding to the size of C-DmManf
was detected in addition to the expected band of approximately
18 kDa (Figure 2A). This suggests that abundantly expressed
DmManf is partially degraded in vivo releasing the C-terminal
domain.
ER Entry but not ER Retrieval is Essential for DmManf
Function in vivo
Both mammalian and Drosophila MANF localize to the ER and
are also secreted [4,9–12,21]. MANF has a signal peptide in the N-
terminus that directs newly synthesized protein into the ER
(Figure 1B). Since MANF has both extracellular neuro-protective
[4,5] and intracellular cyto-protective functions [17], we wanted to
test whether entry into the ER and subsequent secretion of
DmManf is crucial for its functionality. Therefore, we designed a
DmManf transgene with a deletion of the signal sequence (aa ss2–
ss22; DmManf-Dss, Figure 1C). Ubiquitous expression of
DmManf-Dss could not rescue the early larval lethality of DmManf
mutants (Figure 2C) suggesting that DmManf entry into the
secretory pathway via the ER is necessary for its function during
development. Protein expression from DmManf-Dss construct was
confirmed from larvae by Western blot analysis (Figure 2D).
Interestingly, the DmManf-Dss showed lower protein expression
levels than wild type DmManf although the mRNA was expressed
in vivo (Figure 2B). This suggests that DmManf-Dss which is not
targeted to ER and, instead, processed in the cytoplasm is either
unstable or its translation is compromised. Use of two independent
insertions of the DmManf-Dss transgene and two copies of da-
GAL4 driver did not notably increase the expression level (Figure
S1B) and failed to rescue DmManf mutant lethality (Table 2).
We studied the secretion of DmManf-Dss in vitro by transiently
transfecting Drosophila Schneider 2 (S2) and mammalian Chinese
hamster ovary (CHO) cells with V5-DmManf-Dss-pMT and
DmManf-Dss-pCR3.1 constructs encoding V5-DmManf-Dss and
DmManf-Dss, respectively. In S2 cell transfections V5-tagged
Figure 1. Schematic representation of DmManf and HsMANF constructs and a crossing scheme of rescue experiments. A) 3D
structure of HsMANF based on Hellman et al, 2011 [17]. CXXC and RTDL motifs are indicated (image kindly provided by P. Permi). B) Amino acid
sequence alignment of DmManf, HsMANF and HsCDNF. Numbering corresponds to DmManf amino acid residues. Signal sequence (ss), N-terminal
domain and C-terminal domain are coloured in orange, blue and green, respectively. The eight conserved cysteines are indicated with asterisks. C-
terminal CXXC (purple) and RSEL/RTDL/KTEL (red) motifs are rectangled. N-terminal positively charged surface residues mutated in DmManf-NMG1
and DmManf-NMG2 constructs are coloured with white and yellow, respectively. a-helices of HsMANF are marked under the sequence alignment
according to colouring in (A). C–D) Schematic presentation of DmManf (C), HsMANF and HsCDNF (D) constructs. Pink represents start codon, orange
signal peptide, blue N-terminal domain and green C-terminal domain. Red bars correspond to point mutations. In the HsMANF-HsCDNF construct red
corresponds to the HsCDNF sequence. Honeybee melittin was used as a signal peptide in human MANF and CDNF (D) constructs. E) Crossing scheme
used in ubiquitous rescue experiments. Rescued homozygous DmManfD96 mutant pupae were identified by appearance of Tb+ pupae: the expected
proportion of fully rescued DmManfD96 homozygous mutants is 33% (homozygous UAS-lines) or 17% (heterozygous UAS-lines) by Mendelian
inheritance (TM6 Tb Sb balancer homozygotes are lethal at early developmental stage). UAS-x, wild type or mutated transgene.
doi:10.1371/journal.pone.0073928.g001
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Figure 2. Expression analysis of transgenic DmManf constructs and observed rescue of larval lethality. A) Protein expression of
DmManf constructs was verified by Western blotting from 3rd instar larvae. Constructs were ubiquitously expressed by da-GAL4 driver in wild type or
heterozygous DmManf mutant (red typing) background. da-GAL4/+ flies were used as control for endogenous DmManf expression. Schematic
presentation of each construct coloured according to Figures 1B–C is shown under the blot. Calculated molecular weights of full length proteins, N-
and C-terminal domains are presented. L1, L2 etc. correspond to independent transformant lines of each construct. B) In vivo transcription from
constructs encoding DmManf N- and C-terminal domain was verified by RT-PCR from 1st instar larvae. Constructs were expressed by da-GAL4 in
homozygous DmManf mutant background. DmManf and DmManf-Dss were used as positive controls, homozygous DmManf mutant larvae as a
negative control. Schematic presentations of each construct are coloured according to Figures 1B–C. C) Rescue of DmManfD96 mutant larval lethality
by transgenic wild type or mutated constructs of DmManf ubiquitously expressed by da-GAL4. L1, L2 etc. correspond to independent transformant
lines of each construct. Average 6 SD. D) Western blot analysis of protein expression of DmManf constructs with similar to size to endogenous
DmManf (DmManf, DmManf-Dss, DmManf-DRSEL, DmManf-NMG1, and DmManf-NMG2). The constructs were ubiquitously expressed by da-GAL4 in
wild type background. Expression from a transgenic construct is detected as upregulated protein levels in comparison to endogenous DmManf levels
in control flies (da-GAL4/+). L1, L2 etc. correspond to independent transformant lines of constructs. E) Expression analysis of the DmManf-C129S
construct in embryos by Western blotting. Constructs were expressed by da-GAL4 in wild type background. Transgenic expression is detected as
upregulation of DmManf expression compared to da-GAL4 flies (control). In Western blot analyses, alpha-tubulin was used as loading control.
doi:10.1371/journal.pone.0073928.g002
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constructs were used to distinguish endogenously produced
DmManf protein and the protein expressed from transfected
plasmids. After incubation for 72 h, V5-DmManf-Dss and
DmManf-Dss were detected in cell extracts but not in the medium
of S2 or CHO cells by Western blotting (Figure 3A and Figure
S1C) showing that DmManf-Dss was not secreted. We also used
salm-GAL4 to express DmManf and DmManf-Dss in 3rd instar
larval wing discs and detected up-regulation of DmManf
immunoreactivity specifically in the GAL4 expression pattern
(indicated by nuclear GFP; Figure S1D). This in vivo analysis
further indicated a lack of secreted DmManf-Dss since it showed
more strict expression in the GFP-expressing cells whereas wild
type DmManf also localized next to them (white arrows in Figure
S1Dh–i).
We also created a DmManf mutant transgene with deletion of
the putative ER retention signal RSEL (DmManf-DRSEL;
Figure 1B–C) to study whether ER retention of DmManf is
crucial for functionality. Ubiquitously expressed DmManf-DRSEL
rescued the larval lethality of DmManf mutants to adulthood
(Figure 2C and Figure S1E). The localization of DmManf inside
the ER (Figure 3B) in 3rd instar larval garland cells of homozygous
DmManf mutants was significantly decreased when the putative ER
retention signal was deleted (Figure 3B–C). Thus, the retention of
abundantly expressed DmManf in the ER is not essential for fly
viability.
CXXC Motif in the C-terminal Domain is Crucial for in vivo
Functionality of DmManf
The crystal and solution NMR structures of mature HsMANF
and HsCDNF revealed that the C-terminal domain contains a
CXXC motif (residues 127–130) forming a disulphide bridge
(Figure 1A–B) [15–17]. We created a DmManf transgene with a
point mutation that replaces cysteine-129 with serine (C129S;
Figure 1C), a mutation that destroys the CXXC motif and
prevents the formation of the C-terminal disulphide bridge
(Figure 1A). Interestingly, this full-length DmManf transgene with
a mutant C-terminal motif (DmManf-C129S) did not rescue the
DmManf mutant lethality (Figure 2C). Only one of the three tested
insertions resulted in very few rescued pupae (DmManf-C129S L1
in Figure 2C). The expression of DmManf-C129S in Drosophila
under ubiquitous da-GAL4 driver was verified by Western blotting
(Figure 2E). The secretion of V5-DmManf-C129S was not
compromised in comparison to V5-DmManf in transiently
transfected S2 cells analyzed by Western blotting (Figure 3A).
Positive Charge on the Surface of the N-terminal Domain
of DmManf is not Essential for Fly Viability
The N-terminal domain of MANF is characterized by a
globular saposin-fold of five a-helices stabilized by three disulphide
bridges [15–17]. Two groups of positively charged surface amino
acids were identified in the N-terminal domain of HsMANF which
could interact with negatively charged phospholipids in the cell
membrane [15]. To disrupt the putative lipid interaction, we
designed two constructs in which selected positively charged
lysines and arginines of one of the surface amino acid groups were
replaced with neutral alanines: DmManf-NMG1 (N-terminal
Mutant Group 1) containing amino acid changes K79A, K83A
and K86A, and DmManf-NMG2 with mutations K43A, K45A
and R95A (Figure 1C and Figure 2D). In the DmManf mutant
background, neither of these mutation groups abolished the
functionality of DmManf when ubiquitously expressed, i.e. both of
the constructs rescued larval lethality of the DmManf mutants
(Figure 2C).
Table 1. Number of heterozygous pupae in rescue













N-DmManf L7+C-DmManf L3 661
N-DmManf L7+C-DmManf L4 910
N-DmManf L7+C-DmManf-Dss L3 597
N-DmManf L7+C-DmManf-Dss L5 977
N-DmManf-Dss L1+C-DmManf L3 1152
N-DmManf-Dss L1+C-DmManf L4 910
N-DmManf-Dss L1+C-DmManf-Dss L3 781
N-DmManf-Dss L1+C-DmManf-Dss L5 508
No homozygous DmManfD96 mutant pupae were found in any of the rescue
experiments listed here. L:s correspond to independent insertions.
doi:10.1371/journal.pone.0073928.t001
Table 2. Number of heterozygous pupae in rescue experiments with different expression levels of the DmManf-Dss construct.
Construct and insertion da-GAL4 dosage Number of balanced pupae counted
DmManf-Dss L1 1x 1031
DmManf-Dss L5 1x 1065
DmManf-Dss L1+DmManf-Dss L5 1x 1360
DmManf-Dss L5+DmManf-Dss L1 1x 1455
DmManf-Dss L1+DmManf-Dss L5 2x 808
DmManf-Dss L5+DmManf-Dss L1 2x 479
No homozygous DmManfD96 mutant pupae were found in any of the rescue experiments listed here. L:s correspond to independent insertions.
doi:10.1371/journal.pone.0073928.t002
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Increased Dopamine Levels of DmManf Mutants are
Normalized in Rescued Larvae
The lack of endogenous DmManf leads to the loss of
dopaminergic neurites in larval central nervous system (CNS)
[4]. Abolishment of both maternal and zygotic DmManf shows a
substantial decrease in dopamine levels at the end of embryogen-
esis [4]. We wanted to characterize the dopaminergic system of
rescued larvae and compare it with that of the DmManf mutant.
First, we tried to analyze the DA neurites of larval CNS by staining
with an antibody against tyrosine hydroxylase (TH), an essential
enzyme of DA synthesis and a marker for DA neurons.
Unfortunately, this immunohistochemical approach was not
sensitive enough. Instead, we measured the dopamine levels of
DmManf mutants and rescued larvae to address the phenotypes
associated with the dopaminergic system. We collected larvae at
the latest stage when the lethality of homozygous DmManf mutants
occurs. Homozygous DmManf mutants showed a significant
increase in dopamine levels in total larval lysates compared to
wild type larvae (Figure 3D). All constructs driven by da-GAL4
that were able to rescue larval lethality (DmManf, DmManf-
DRSEL, DmManf-NMG1 and DmManf-NMG2) also normalized
larval dopamine to the wild type level (Figure 3D).
Figure 3. Deletion of RSEL sequence affects secretion and intracellular localisation of DmManf. A) Western blot analysis of cellular and
secreted DmManf in vitro. Schneider 2 cells were transiently transfected with wild type and mutated V5-DmManf-pMT constructs. DmManf protein
levels in cell lysates and conditioned medium were estimated according to Figure S1G. Band intensities were normalised to DmManf. Alpha-tubulin
was used as a loading control. B) DmManf-DRSEL driven by ubiquitous da-GAL4 (b, d and f) showed decreased endoplasmic reticulum (ER)
localisation compared to wild type DmManf (a, c and e) in 3rd instar larval garland cells of homozygous DmManfD96 mutants. Yellow (e and f)
represents the co-localisation of the ER marker (sqh-EYFP-ER; green; a and b) EYFP and a-DmManf (red; c and d). Nuclei were stained with DAPI (blue;
e and f). C) Quantification of (B). Deletion of the putative ER retention signal (RSEL) significantly decreased the proportion of ER localised DmManf of
total cellular DmManf in 3rd larval garland cells compared to the wild type construct. Average 6 SEM, n=13. ***, P,0.001, Student’s t-test. D)
DmManf mutant (2/2) larvae (n= 13) showed significant increase in dopamine concentration in comparison to wild type (n=8). Ubiquitous
expression of DmManf (n= 11), DmManf-DRSEL (n= 10), DmManf-NMG1 (n= 8) or DmManf-NMG2 (n= 10) by da-GAL4 in homozygous DmManf
mutant background rescued dopamine concentration to the wild type level. ***, P,0.001 versus wild type, Student’s t-test.
doi:10.1371/journal.pone.0073928.g003
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Restricted Expression of Mutated Constructs Reveals
their Effects on DmManf Functionality
When expression of DmManf constructs is driven by da-GAL4,
proteins encoded by transgenes are available abundantly and
ubiquitously in all tissues. This may mask the effects of mutations,
especially if they affect the proportion of secreted MANF,
intracellular dynamics or extracellular distribution of the protein.
To assess this, we expressed DmManf, DmManf-DRSEL,
DmManf-NMG1 and DmManf-NMG2 transgenes by a non-
ubiquitous 69B-GAL4 which is not expressed in muscles, fat body
or gastric caeca. Expression in the CNS and cuticle is clearly
decreased compared to da-GAL4. Despite the restricted expression
pattern, the wild type DmManf construct driven by 69B-GAL4
resulted in full rescue of the DmManf mutant (Figure 4A and Figure
S1E) as previously shown [4]. The overall GAL4 expression level
was slightly weaker in 69B-GAL4 than da-GAL4 analyzed by
Western blotting (Figure S1F). However, with both drivers the
expression of ectopic DmManf was clearly higher than the
endogenous level of DmManf (Figure S1F).
Deletion of the ER retention signal (DmManf-DRSEL) clearly
reduced the proportion of rescued pupae with 69B-GAL4 driver
compared to ubiquitous da-GAL4 driver (Figure 4A). We analyzed
whether the DRSEL mutation affected the secretion of DmManf
by transiently transfecting S2 cells with V5-DmManf-pMT and
V5-DmManf-DRSEL-pMT plasmids. In comparison to V5-
DmManf, the level of cellular V5-DmManf-DRSEL protein was
clearly decreased while the level of secreted V5-DmManf-DRSEL
in the medium was at least as high as the level of secreted V5-
DmManf, indicating that the proportion of secreted DmManf was
increased (Figure 3A). These data suggest that ER retention is
important for correct DmManf function when protein availability
is spatially and/or temporally restricted.
When expressed by 69B-GAL4 driver, DmManf-NMG2 fully
rescued the larval lethality of DmManf mutants similar to the wild
type DmManf construct (Figure 4A). In contrast, restricted
expression of the DmManf-NMG1 construct by 69B-GAL4 lead
to almost complete loss of rescued DmManf mutant pupae
(Figure 4A). Similar amounts of secreted and cellular V5-DmManf
were detected from S2 cells transiently transfected with V5-
DmManf-pMT, V5-DmManf-NMG1-pMT and V5-DmManf-
NMG2-pMT constructs (Figure 3A). These data demonstrate that
the neutralization of positively charged surface amino acids K79,
K83 and K86 (DmManf-NMG1) but not K43, K45 and R95
(DmManf-NMG2) affect other molecular properties of DmManf
than the secretory efficacy.
DmManf is Functionally more Related to Human MANF
than CDNF
In our previous studies transgenic human CDNF (HsCDNF-
6N9C; Figure S2A) did not rescue the DmManf mutant lethality
[4]. Because the HsCDNF-6N9C construct used in the previous
rescue experiments encoded HsCDNF with some extra N- and C-
terminal amino acid residues (which were introduced into the
construct during cloning) we decided to remove these additional
residues and generate a new HsCDNF transgene (Figure 1D). To
our surprise, this HsCDNF transgene expressed by da-GAL4
could, as efficiently as HsMANF, rescue the DmManf mutant
lethality to adulthood (Figure 4B and Figure S1E). The extra N-
terminal amino acids were likely responsible for deficient
functionality of the HsCDNF-6N9C construct (Figure S2A–C).
To study the functionality of the independent N- and C-
terminal domains of human MANF and CDNF in the Drosophila
in vivo model, we designed mutated human MANF (N-HsMANF,
C-HsMANF, C-HsMANF-Dss; Figure S3A) and CDNF (N-
HsCDNF, C-HsCDNF, C-HsCDNF-Dss; Figure S2A) constructs.
In line with the corresponding DmManf constructs (see above),
these constructs could not rescue the larval lethality of DmManf
mutants (Table 3). While only N-HsCDNF was detected from
larval lysates by Western blotting (Figures S3B–C), mRNA
expression was verified by RT-PCR from adult fly lysates of all
of these constructs (Figures S3D–E).
We used non-ubiquitous expression of the HsMANF and
HsCDNF transgenes to rescue DmManf mutant lethality by 69B-
GAL4 driver. With a restricted expression pattern, HsMANF
could fully rescue DmManf mutant lethality to adulthood, while
HsCDNF showed clearly decreased amount of rescued pupae and
no emerging adults (Figure 4A and Figure S1E). This suggests that
human MANF and CDNF have diverged during evolution. We
also asked whether the C-terminal domain of HsCDNF could
complement the function of C-HsMANF by replacing the C-
terminal domain of HsMANF (residues 105–158) with that of
HsCDNF (residues 101–164; HsMANF-HsCDNF; Figure 1D).
Ubiquitous expression of this construct rescued DmManf mutant
lethality to adulthood (Figure 4B and Figure S1E). However, the
proportion of rescued pupae with restricted expression of
HsMANF-HsCDNF was clearly decreased compared to
HsMANF, but closely resembled that of HsCDNF (Figure 4A).
This demonstrated that functional properties of the C-terminal
domain of HsCDNF differ from HsMANF and DmManf. To test
this hypothesis we designed a construct with the N-terminal
domain of HsCDNF (residues 1–100) and the C-terminal domain
of HsMANF (residues 96–158), but failed to obtain transgenic flies.
We found that ubiquitous but not restricted expression of
HsMANF-DRTDL, an HsMANF transgene with deletion of the
ER retention signal RTDL (Figure 1D), could rescue DmManf
mutant lethality (Figure 4B and Figure S1E). Correspondingly, the
DmManf construct (DmManf-DRSEL) expressed in a restricted
pattern decreased the amount of rescued DmManf mutant pupae.
This further supports the importance of ER retained MANF
during fly development.
DmManf Rescues Mouse SCG Neurons from Apoptosis
in vitro
After studying the functionality of mammalian MANF/CDNF
in the Drosophila system we addressed the opposite, i.e. can
DmManf rescue the mammalian cells. We used cultured apoptotic
SCG neurons overexpressing the MANF constructs as this is
currently the only reliable mammalian in vitro bioassay for MANF/
CDNF. At neonatal stage the SCG neurons require nerve growth
factor (NGF) for survival but are also sensitive to other apoptotic
stimuli, thus being an excellent model to test the survival-
promoting compounds. Our recent studies have shown that a
plasmid encoding HsMANF or purified recombinant HsMANF
protein protects mouse SCG neurons from apoptosis when
microinjected into the neuronal nucleus or cytoplasm, respectively
[17]. Independent cytoplasmic C-HsMANF-Dss also shows
survival promoting activity in SCG neurons. Interestingly,
overexpressed HsMANF protects the neurons against etoposide
treatment, but only marginally against NGF deprivation [17]. We
microinjected the NGF-maintained SCG neurons derived from
neonatal (P0) mouse with DmManf-pCR3.1 and C-DmManf-Dss-
pCR3.1 plasmids and treated neurons with etoposide to induce
apoptosis. Importantly, both full-length DmManf with the
endogenous fly signal peptide and the intracellular C-DmManf-
Dss were able to rescue mouse SCG neurons from apoptosis
(Figure 4C), similar to HsMANF in vitro [17]. To eliminate the
possibility of intracellular DmManf leakage from apoptotic cells
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into the medium, we transfected etoposide-treated mammalian
CHO cells with DmManf-pCR3.1 and DmManf-Dss-pCR3.1
constructs. In contrast to DmManf, no DmManf-Dss protein was
detected in the medium sample by Western blot analysis (Figure
S1C).
Discussion
A neuro-protective function for MANF and CDNF has been
demonstrated both in vitro [2,17] and in vivo [3–6]. Since very little
is known about the mechanism of MANF and CDNF action, we
used a transgenic approach in the Drosophila Manf mutant model to
characterize the structural features of MANF/CDNF proteins
Figure 4. DmManf shares conserved functions with human MANF and CDNF. A) Comparison of the rescue efficacy of DmManfD96 mutant
lethality between ubiquitous da-GAL4 and non-ubiquitous 69B-GAL4 drivers with selected transgenic DmManf, HsMANF, and HsCDNF constructs. L1,
L2 etc. correspond to independent transformant lines of each construct. Average 6 SD. B) Rescue of DmManfD96 mutant larval lethality by transgenic
wild type or mutated constructs of HsMANF and HsCDNF ubiquitously expressed by da-GAL4. L1, L2 etc. correspond to independent transformant
lines of each construct. Average 6 SD. C) Full-length DmManf (n= 5) and an independent C-terminal domain (C-DmManf-Dss, n= 2) rescued superior
cervical ganglion neurons from apoptotic deathsimilar to HsMANF and C-HsMANF [17]. The NGF-maintained neurons were microinjected with the
indicated expression plasmids or empty vector (negative control) and treated with etoposide (30 mM). The injected neurons were identified by the
EGFP expression of the co-injected EGFP plasmid. Living neurons were counted three days later and presented as a proportion of the original injected
neurons. The NGF-maintained untreated neurons show that no cell death occurs without etoposide treatment. Average 6 SEM. **P,0.01 versus
control plasmid (Vector) by one-way ANOVA and post hoc Dunnett’s test.
doi:10.1371/journal.pone.0073928.g004
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needed for activity in vivo. We first used ubiquitous expression of
transgenes and based on obtained results, used non-ubiquitous
expression of selected transgenes. While ubiquitous abundant
expression should provide sufficient MANF concentration for all
cells it could mask some effects of the designed mutations affecting
intracellular dynamics, extracellular distribution, or ratio of intra-
and extracellular MANF levels. Therefore restricted expression (in
which the transgenic wild type DmManf construct fully rescues)
may reveal the effects of mutations more efficiently.
Previous studies have demonstrated that MANF is an ER
resident protein upregulated by ER stress [9–12,21]. Loss of the
relatively weak ER retention signal RTDL leads to increased
secretion of MANF [8,22]. In this study we showed that deletion of
the C-terminal RSEL sequence also increased secretion of
DmManf and significantly decreased its localization to the ER.
We found that ER retention of MANF was not absolutely
necessary for MANF function in vivo since ubiquitously expressed
DmManf-DRSEL was able to rescue DmManf mutant lethality.
However, the restricted expression of DmManf-DRSEL or
HsMANF-DRTDL did not fully rescue DmManf mutant lethality.
This suggests that limited availability of MANF inside the cell
compromises the intracellular functions of MANF.
Our study showed that signal sequence-mediated entry to the
secretory pathway via the ER is crucial for the proper function of
MANF since DmManf-Dss was unable to rescue DmManf mutant
lethality. Furthermore, the MANF protein synthesized in the
cytoplasm seemed to be unstable. In future studies, it would be
important to address whether the loss of the ER resident or
secreted pool of MANF was crucial for the functional failure of the
DmManf-Dss mutant.
Interestingly, we found that the CXXC motif in the C-terminal
domain is crucial for DmManf function in vivo since the DmManf-
C129S mutant could not complement for the loss of the
endogenous DmManf protein. One possibility is that MANF
could relieve ER stress by helping proteins to fold properly [1] by
facilitating intracellular disulphide bond formation via the C-
terminal CXXC motif and thus functionally resemble thiol/
oxidoreductases [1,20]. However, no oxidoreductase activity of
MANF was found in vitro [9]. Mutation of cysteine-129 abolishes
the CXXC disulfide bond which may result in an inactive
conformation of the protein. The thiol groups could also perform
other essential functions, such as redox signaling or metal ion
binding that might be defected in the DmManf-C129S mutant.
Additionally, the MANF CXXC motif is within the EF-hand Ca2+
binding domain (FlyBase ID FBgn0027095, [23]). A C129S
mutation putatively affecting the folding or conformation of the C-
terminal domain might lead to loss of Ca2+-dependent GRP78
binding to MANF.
In contrast to zygotic and maternal DmManf mutant embryos
[4], the homozygous zygotic DmManf mutant larvae showed
increased dopamine levels. Microarray analysis [12] revealed in
both embryonic and larval DmManf mutants upregulation of TH
transcript expressed specifically in the hypoderm [24]. Hypoder-
mal cells give rise to cuticle where DA derivatives are used as
cross-linkers. In zygotic and maternal DmManf mutant embryos
with decreased DA levels the total lack of DmManf could lead to
deficient DA synthesis despite increased TH transcript levels.
While the zygotic mutant larvae still possess a pool of maternal
DmManf, increased DA synthesis might remain with an increased
rate due to the elevated amounts of TH until the maternal pool of
DmManf has been depleted.
DmManf also efficiently protected apoptotic mammalian
neurons. Although the in vitro SCG neuron model and the in vivo
fly rescue models are not directly comparable, this result shows
that the basic neuro-protective function of MANF has persisted
during evolution. However, the protective mechanisms in these
two models may significantly differ, as C-DmManf-Dss protected
SCG neurons but was ineffective in rescuing the mutant fly
phenotype. Moreover, the MANF/CDNF N- or C-terminal
domains alone, even if expressed together within the same cells,
could not rescue the larval lethality of DmManf mutants
demonstrating that an intact full-length protein is crucial for fly
viability.
In conclusion, our study provides the first in vivo demonstration
of structural and functional determinants of the MANF/CDNF
protein family.
Materials and Methods
Fly Stocks and Maintenance
Flies were maintained at 25uC on malt-based media. The fly
stocks used were: w-, UAS-DmManf133 (insertion L3), UAS-
DmManf135 (insertion L5), UAS-HsCDNF-6N9C, and
DmManfD96/TM6 Tb Sb [4]; UAS-lacZ [25]; UAS-GFP.nls
#4775 [26], sqh-EYFP-ER #7195 [27], da-GAL4 #5460 [28],
69B-GAL4 #1744 [25], tub-GAL4 #5138 [29], and salm-GAL4
#5818 [30] from Bloomington Drosophila Stock Center.
Generation of Transgenic Flies
Mutations were generated by PCR mutagenesis using PhusionH
Hot Start High-Fidelity DNA polymerase (Finnzymes) and
subcloned into the pUAST vector [25] (Table S1). Most mutations
were created on templates in pBlueScript SK or pCR3.1
(Invitrogen) vectors (Table S1). The remaining constructs or
templates were created according to the following (numbers
correspond to Table S1, primers are listed in Table S2): (1)
DmMANF-K95A-Bluescript was created by inverse PCR
mutagenesis with primers DmMANF_R95A.fwd and
DmMANF-Nterm.rev, DmMANF-BlueScript [4] was used as a
template; (2) HsMANF-pCR3.1 – HsMANF with honeybee
melittin secretion signal [4] was subcloned as an EcoRI-XhoI
fragment from the pUAST vector into pCR3.1. To create FL-
HsMANF without extra C-terminal residues, a stop codon was
introduced by PCR; (3) HsMANF-HsCDNF-pCR3.1 – a C-
Table 3. Number of heterozygous pupae in rescue
experiments with N- and C-terminal constructs of HsMANF
and HsCDNF.












No homozygous DmManfD96 mutant pupae were found in any of the rescue
experiments listed here. L:s correspond to independent insertions.
doi:10.1371/journal.pone.0073928.t003
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terminal fragment of HsCDNF with Bpu10I and XhoI sites was
generated by PCR. FL-HsMANF in pCR3.1 was restricted with
Bpu10I and XhoI and the C-terminus of HsMANF was replaced
with C-HsCDNF; (4) NaeI-HsCDNF-pCR-II – a PCR fragment
of HsCDNF with an N-terminal NaeI site and a C-terminal stop
codon was created and ligated into the pCRII (Invitrogen) vector.
The cDNA encoding CDNF in HsCDNF-6N9C-pUAST [4] was
replaced with a NaeI- HsCDNF- XhoI fragment from pCRII to
create HsCDNF-pUAST; (5) HsCDNF-Bluescript was cloned
as a NotI-XhoI fragment from a PCR product in which HsCDNF-
pUAST was used as a template with the primers NotI-CDNF-
pUAST.fwd and CDNF-pUAST-XhoI; (6) C-HsCDNF-Dss-
pUAST was cloned as a BglII-XhoI fragment from a PCR product
of NaeI-HsCDNF-pCR-II with the primers BglII-M-HsCDNF-
Cterm.fwd and HsCDNF-TOPO-XhoI.rev; (7) HsCDNF-6N-
BlueScript was subcloned as a NotI-BglII fragment from
HsCDNF-6N9C-delStop-BlueScript to HsCDNF-BlueScript; (8)
HsCDNF-6N9C-del(stop)-Bluescript was cloned as a NotI-
XbaI fragment from a PCR product in which HsCDNF-6N9C-
pUAST [4] was used as a template with the primers NotI_CDN-
F_old_pUAST.fwd and CDNF_old_pUAST_XbaI.rev. The tem-
plate vector DmManf in pBlueScript was kindly provided by M.
Palgi [4]. All constructs were verified by sequencing. Honeybee
melittin was used as a signal peptide in human MANF and CDNF.
Transgenesis was performed by Genetic Services, Inc. Selected
insertions in the 2nd chromosome were combined with DmManfD96
mutations balanced against TM6 Tb Sb.
Rescue Experiments
Five GAL4 DmManfD96/TM6 Tb Sb females were crossed to 2–
3 UAS-x(/CyO); DmManfD96/TM6 Tb Sb males. Five parallel
crosses were done and transferred twice to new vials every 2–
3 days. Normal (Tb+) and short (Tb-) pupae were counted 9–
10 days after egg laying (AEL). The amount of normal pupae was
divided by the amount of all pupae and the ratio normalized by
0.33 (homozygous UAS lines) or 0.17 (heterozygous UAS lines).
For quantification of rescued adults, amounts of rescued pupae
(Tb+) and adults (Sb+) were counted 10 days AEL and daily 10–
14 AEL, respectively. Emerged adults are presented as proportion
of rescued pupae.
Immunoblotting
Larvae were homogenized in 300 ml lysis buffer (20 mM Tris-Cl
pH 7.4, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA)
supplemented with Complete proteinase inhibitor tablets (Roche).
Cultured cells were washed once with PBS and lysed in membrane
lysis buffer (TBS, 1% Triton X-100, 20 mM NaF, 1 mM EDTA,
pH 7.5) containing Complete proteinase inhibitor tablets (Roche).
Insoluble material was sedimented by centrifugation and protein
concentration in the cleared lysates was measured using Bradford
reagent (Bio-Rad). Samples were run on 14% or 15% SDS-PAGE
and transferred onto nitrocellulose filters. The filters were
incubated in blocking buffer overnight (5% non-fat dried milk in
TBS +0.1% Tween-20) and then incubated in primary antibodies
diluted in blocking buffer for 1 hour. Antibodies used were rabbit
anti-CDNF [3], rabbit anti-MANF [21], rabbit anti-DmManf [4],
anti-V5 (Invitrogen), anti-a-tubulin (DM1A, Sigma) and anti-
acetylated a-tubulin (6-11B-1, Sigma; Figures 2A, 2D and S1F).
Secondary antibody incubations and enhanced chemilumines-
cence detection were performed according to standard protocols.
Molecular weights were approximated by using the science
gateway Protein Molecular Weight calculator (http://www.
sciencegateway.org/tools/proteinmw.htm). For infrared imaging,
blots were incubated with IRDye secondary antibodies (Li-Cor,
Lincoln, NE, USA) according to the manufacturer’s instructions.
Blots were visualized by the Odyssey infrared imager (Li-Cor) and
band intensities were estimated using the ImageJ program [31].
Immunohistochemistry, Confocal Microscopy and Image
Analysis
Third instar larvae were fixed and immunostained with rabbit
anti-DmManf [4] according to standard protocols. Samples were
analyzed with TCS SP5 AOBS (Leica Microsystems) equipped
with HCX PL APO 20x/0.7 Imm Corr (glycerol) or HCX APO
63x/1.30 Corr (glycerol) CS 21 objectives. ImageJ 1.43u was used
to create representative images of confocal stacks [31]. AutoQuant
X3 (MediaCybernetics) was used in deconvolution and Imaris
7.6.0 (Bitplane AG) in quantification of ER localized and total
cellular DmManf.
Constructs used in Transient Transfection
DmManf-Dss cDNA was subcloned from the corresponding
construct in pBlueScript (Table S1) to the pCR3.1 vector as a PstI–
XhoI fragment. V5-DmManf-pMT, V5-DmManf-Dss-pMT, V5-
DmManf-DRSEL-pMT, V5-DmManf-C129S-pMT, V5-
DmManf-NMG1-pMT, and V5-DmManf-NMG2-pMT were
cloned as follows: V5-tag was added to the corresponding
constructs in pBlueScript (Table S1) by inverse PCR mutagenesis
with forward primer V5Dm.F and reverse primers V5-Dm-5atg.R
(DmManf-Dss) or V5-Dm-ss.R (other constructs) and subcloned as
EcoRI-XhoI fragments to pMT(A) (Invitrogen).
Transfection of S2 and CHO Cells
Schneider 2 (S2) cells were cultured in M3-BPYE medium
(Shields and Sang M3, 0.5 g/l KHCO3, 1.0 g/l yeast extract,
2.5 g/l bactopeptone and 10% fetal bovine serum, pH 6.6) at
+25uC. Transfections were performed using Fugene HD reagent
(Roche). Expression from the metallothionein promoter of pMT
was induced with 600 mM CuSO4. Media and cells were collected
3 days post-transfection. Chinese hamster ovary (CHO) cells were
cultured in DMEM, 10% fetal bovine serum and antibiotics. The
cells were plated in 12-well plates and on the following day
transfected with the expression plasmids using Fugene HD reagent
(Roche). After 3 days media and cells were collected.
Dopamine Concentration Measurements
Larvae were collected from apple juice plates 50–55 h after egg
laying in 0.5–3.2 mg samples and homogenized with an ultrasonic
processor. Analysis was done with high-performance liquid
chromatography (HPLC) using a Gemini C18 3 mm,
4.6675 mm, column (Phenomenex). A 12-channel ESA CoulAr-
ray Electrode Array Detector system and CoulArray for Windows
software (ESA inc.) was used for quantification of dopamine [32].
Dopamine was identified by both exact retention time and
characteristic electrochemical properties.
RT-PCR
Total RNA was extracted from 50 1st instar larvae (DmManf
samples) or 5 adults (HsMANF and HsCDNF samples) by RNeasy
Mini Kit (Qiagene) and treated with RQ1 RNase-Free DNase
(Promega). M-MLV Reverse Transcriptase (Promega) was used in
cDNA synthesis and GoTaqH Hot Start Polymerase in PCR
reaction. Primers and expected sizes of PCR products are listed in
Table S3.
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Microinjection of SCG Neurons
DmManf and C-DmManf-Dss cDNA:s were subcloned from
corresponding constructs in pBlueScript (Table S1) to the pCR3.1
vector as PstI-XhoI fragments. SCG neurons were prepared from
neonatal mice anesthetized by hypothermia and sacrificed by
decapitation. All procedures for animal use were approved by the
University of Helsinki Laboratory Animal Centre (Protocol
number KEK11-020). Neurons were cultured with NGF (Pro-
mega) for 5–6 days and microinjected with the plasmids encoding
for the respective DmManf constructs or the empty vector
(negative control) together with the reporter plasmid of EGFP.
Immediately after microinjection, the neurons were treated with
30 mM of etoposide (Sigma-Aldrich) in the presence of NGF.
Living EGFP-expressing neurons were counted three days later in
a ‘‘blind’’ manner and expressed as percent of original injected
neurons. The NGF-maintained untreated neurons show the
absence of cell death without etoposide. Average 6 SEM of 2–5
independent experiments is shown. Data from each experimental
group was compared with control plasmid pCR3.1-injected
neurons (vector).
Statistical Analysis
The means were compared by one-way ANOVA and post hoc
Dunnett’s test (SCG neuron analysis) or by Student’s t-test
(dopamine concentration analysis and ER-localised DmManf
analysis). The null hypothesis was rejected at p,0.05. Statistical
analysis was performed by using GraphPad InStat 3 program
(GraphPad Software, Inc.; SCG neuron analysis) or MicrosoftH
Excel Analysis ToolPak (MicrosoftH Office Professional Plus 2010;
other analyses).
Supporting Information
Figure S1 Additional information of mutated DmManf
constructs. A) Schematic presentation of combinations of
DmManf N- and C-terminal domain constructs (with or without
secretion signal peptide). Colours are according to Figure 1C.
Results of each rescue experiment are presented in Table 1. B)
Expression analysis of the DmManf-Dss construct in wild type
background by Western blotting from 3rd instar larvae. Expression
level of the DmManf-Dss was increased by two copies of construct
and by two copies of da-GAL4 driver and compared to that of the
DmManf construct and endogenous expression of DmManf in
wild type. C) Western blot analysis of transiently transfected
Chinese hamster ovary cells reveals that the DmManf-Dss is not
secreted while DmManf and DmManf-DRSEL are. Etoposide
treatment does not cause leakage of DmManf-Dss from cells into
the medium. D) In vivo expression analysis of DmManf (b, e and h)
and DmManf-Dss (c, f and i) constructs in wing discs of 3rd instar
larvae overexpressed by salm-GAL4. Overexpression of lacZ (a, d
and g) was used as a control for endogenous DmManf. Transgene
expression was detected as upregulation of DmManf immunore-
activity (red; d–f) in salm-GAL4 expression pattern marked by
nuclear GFP (GFP.nls in green; a–c). White arrows (h and i)
indicate the secreted DmManf. E) Rescue of DmManfD96 mutant
pupal lethality by wild type or mutated DmManf, HsMANF or
HsCDNF. Wild type flies were used as control. Average 6 SD. F)
Expression level of da-GAL4 and 69B-GAL4 in 3rd instar larvae by
Western blot analysis. Endogenous DmManf expression in wild
type background was compared to transgenic DmManf (L5)
expressed by da-GAL4 or 69B-GAL4 in homozygous DmManfD96
mutant background. G) Western blot analysis of cell lysates and
medium from Schneider 2 cells transiently transfected with wild
type and mutated V5-tagged DmManf-pMT constructs. Band
intensities were normalised to DmManf. In Western blotting
analyses, alpha-tubulin was used as loading control.
(TIF)
Figure S2 Extra N-terminal amino acid residues disrupt
HsCDNF functionality in vivo. A) Schematic presentation of
HsCDNF, HsCDNF-6N9C, HsCDNF-6N, HsCDNF-9C, N-
HsCDNF, C-HsCDNF and C-HsCDNF-Dss constructs, colours
according to Figure 1B. Since either the N- or C-terminal extra
residues of HsCDNF-6N9C, or both, could be responsible for the
loss of its functionality, we designed two HsCDNF transgenes, one
with extra N-terminal residues (SLLTQG; HsCDNF-6N) and the
other with extra C-terminal residues (LEGTSRGSL; HsCDNF-
9C). Gray boxes indicate the additional N- and C-terminal amino
acids in HsCDNF-6N9C, HsCDNF-6N and HsCDNF-9C
constructs. Honeybee melittin was used as a secretion signal. B)
Similarly to HsCDNF, HsCDNF-6N9C is expressed and secreted
from transiently transfected Schneider 2 cells. Thus, the negative
rescue result by HsCDNF-6N9C was likely not due to an
expression or secretion defect. C) HsCDNF-6N9C fails to rescue
DmManfD96 mutant lethality while HsCDNF-9C fully rescues,
similar to the HsCDNF construct. HsCDNF-6N shows only mild
rescue of DmManfD96 mutant lethality. This suggested that the
extra six N-terminal residues in the original HsCDNF-6N9C
construct were responsible for the loss of functionality. Constructs
were ubiquitously expressed by da-GAL4. L, independent
insertions of the constructs.
(TIF)
Figure S3 Independent N- and C-terminal domains of
HsMANF and HsCDNF fail to rescue DmManf mutant
lethality. A) Schematic presentation of HsMANF, N-HsMANF,
C-HsMANF and C-HsMANF-Dss constructs. N- and C-terminal
domain constructs failed to rescue DmManf mutant lethality
(Table 3). Colours are according to Figure 1B. B–C) Protein
expression of HsMANF (B) and HsCDNF (C) constructs was
verified by Western blotting from 3rd instar larvae. Constructs
were ubiquitously expressed by tub-GAL4 driver in the wild type or
heterozygous (red typing) DmManf mutant backgrounds. Coloured
boxes under the blot indicate the domains of the construct
corresponding to Figure S2A and Figure S3A. Calculated
molecular weights of full length proteins, N- and C-terminal
domains are presented next to Western blot images. L,
independent insertions of the constructs. Alpha-tubulin was used
as a loading control. D–E) Transcription from N- and C-terminal
domain constructs of HsMANF (D) and HsCDNF (E) was verified
by RT-PCR from adult flies. Constructs were expressed by tub-
GAL4 in wild type background. Wild type HsMANF and
HsCDNF constructs were used as positive controls, wild type flies
as negative controls. Coloured boxes indicate the domains of the
construct corresponding to Figure S2A and Figure S3A.
(TIF)
Table S1 List of constructs used in generation of
transgenic flies. Cloning primers are presented in Table S2.
Cloning details for 1–8 are presented in Materials and Methods.
del, deletion; ins, insertion; ss, secretion signal.
(PDF)
Table S2 List of primers used in cloning of constructs
for generation of transgenic flies and in RT-PCR.
(PDF)
Table S3 Primer pairs used in RT-PCR to detect mRNA
expression.
(PDF)
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